PremiumCompany AnnouncementsSareum Holdings Secures £1.07 Million in Institutional Fundraise Sareum Holdings Acquires Licence for SRA737, Strengthening Oncology Portfolio Sareum Holdings Refocuses Strategy After SRA737 Licensing Termination PremiumCompany AnnouncementsSareum Holdings Announces AGM and Progress in Drug Development Sareum Holdings Advances in Autoimmune and Cancer Drug Development Sareum Holdings Secures Additional Funding for Drug Development PremiumCompany AnnouncementsSareum Holdings Reports Promising Phase 1 Results Sareum Holdings Appoints New Sole Broker Sareum Holdings Announces Warrant Exercise and Share Issue